4//SEC Filing
Mekhail Adel 4
Accession 0001104659-24-119387
CIK 0001295947other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 7:41 PM ET
Size
9.6 KB
Accession
0001104659-24-119387
Insider Transaction Report
Form 4
Mekhail Adel
EVP, Marketing & Sales
Transactions
- Exercise/Conversion
Common Stock, par value $0.01 per share
2024-11-12$44.33/sh+5,565$246,696→ 27,428 total - Sale
Common Stock, par value $0.01 per share
2024-11-12$82.00/sh−9,063$743,166→ 18,365 total - Exercise/Conversion
Employee Stock Options (rights to buy)
2024-11-12−5,565→ 5,400 totalExercise: $44.33Exp: 2031-05-03→ Common Stock (5,565 underlying)
Footnotes (2)
- [F1]Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $81.92 to $82.02.
- [F2]The options vested in three equal installments of 3,655 shares on May 4, 2021, May 4, 2022 and May 4, 2023.
Documents
Issuer
Prestige Consumer Healthcare Inc.
CIK 0001295947
Entity typeother
Related Parties
1- filerCIK 0001776953
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 7:41 PM ET
- Size
- 9.6 KB